Reliance Industries Limited (RIGD)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 49.90 |
|---|---|
| 52-week range | 47.85 – 71.10 |
| Return, 1 month / 3 months | −2.7% / −3.7% |
| Return, 1 year / 3 years | −23.9% / −7.5% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 23.4% |
| Worst drawdown (1 year) | -31.8% |
| Average daily value traded | 5.43M USD |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Reliance Industries Limited is an Indian conglomerate based in Mumbai. Its businesses span energy and materials, including oil refining and the production of petrochemicals and polymers, alongside a telecommunications network serving consumers and a retail chain of stores selling food, groceries and household goods. The company also runs a digital services arm and a media and entertainment business, and it operates in India and through trading and marketing activities in other markets.
On this site Reliance Industries Limited appears as a stock on the London Exchange (UK), code RIGD, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Reliance Industries Limited (RIGD) trades on the London Exchange in UK. It last closed at USD 49.90 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 2,534 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.9% and over the last three months it fell 3.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.8% | ||
| From 52-week high | -29.7% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.7% | ||
| 6-month return | -13.6% | ||
| 12-month return, skipping the last month | -21.7% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 23.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.8% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 5.43M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 20 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.3% |
|---|---|
| 1 month | −2.7% |
| 3 months | −3.7% |
| 6 months | −13.6% |
| 1 year | −23.9% |
| 3 years | −7.5% |
| 5 years | −25.0% |
Signals
| 50-day / 200-day average | 52.02 / 56.56 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | INR 0.2130 |
| 13 Aug 2025 | INR 0.2122 |
| 16 Aug 2024 | INR 0.2019 |
| 17 Aug 2023 | INR 0.1824 |
| 19 Jul 2023 | INR 4.1392 |
| 17 Aug 2022 | INR 0.1691 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.